Unjha Formulations Ltd
Unjha Formulations Ltd Live Price Chart
Performance
| Previous Close | ₹ 27 |
| High | ₹ 28 |
| Volume | 2062 |
| 52W Range | ₹ 17.52 - ₹ 29.5 |
| Open | ₹ 28 |
| Low | ₹ 27.1 |
| Market Cap | ₹ 10.67 Cr |
Unjha Formulations Ltd Technicals
| 20 Day | ₹ 25.762 |
| 50 Day | ₹ 23.849 |
| 100 Day | ₹ 22.749 |
| 200 Day | ₹ 22.803 |
| 20 Day | ₹ 25.886 |
| 50 Day | ₹ 22.842 |
| 100 Day | ₹ 21.362 |
| 200 Day | ₹ 22.532 |
Unjha Formulations Ltd Fundamentals
| ROCE | 25.022 |
| P/E Ratio | 26.240 |
| P/B Ratio | 3.210 |
| Industry P/E | 3.210 |
| Debt to Equity | 50.646 |
| ROE | 18.335 |
| EPS | 1.050 |
| Dividend Yield | 0.000 |
| Book Value | 8.578 |
| Face Value | 10.000 |
Unjha Formulations Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 | Y202203 |
|---|---|---|---|---|---|
| Total Revenue | 15.7488 | 13.9767 | 18.5075 | 13.1844 | 14.3506 |
| Total Expenses | 14.7949 | 13.4532 | 18.0557 | 12.8548 | 14.051 |
| Profit After Tax | 0.7048 | 0.4075 | 0.2779 | 0.2825 | 0.2525 |
Unjha Formulations Ltd Shareholding Pattern
| Promoter Holdings | 36.925 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 55.477 % |
| Others - | 7.598 % |
About Unjha Formulations Ltd
Unjha Formulations Limited was established in June, 1987 as a Partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat. The Company is a pioneer in Isabgol (Psyllium) Formulation. The Company is in service to Isabgol (Psyllium) Ayurvedic formulation profession. The company manufactures pharmaceutical formulations like liquids, powder, tablets, capsules, injectibles, etc. It is one of the largest manufacturers of isabgul products in India. The company's products are classified under two divisions -- human consumption and veterinary products. Company launched four new products viz.Bericof, Protobal-NT, Formentin Tablets and Nalizole in the year 1997-98. The Company commenced its commercial production and was successfully expanding its customer base throughout the Country including U.P. Territory. Company also interested on development of Export Markets for Ferrous Sulphate, Albendazole Bolus and Iron Folic Tablets to supplement the present law domestic demand situation and achieved export turnover of Rs.0.98 during the year 1997-98. During 2002-03, the Company made manufacturing agreement with Nicholas Piramal India Limited for sale of Isabgol Husk based product TYBOGEL' and Morepen Laboratories Ltd. for sale of Dr.Mopren Sat Isabgol. It had manufacturing agreement with Karnataka Antibiotics & Pharmaceuticals Limited for sale of Isabgol Husk based products and other veterinary products on Loan Licence basis. In 2026, ...
FAQs on Unjha Formulations Ltd
1. Can I buy Unjha Formulations Ltd from PL Capital? ›
2. Does Unjha Formulations Ltd pay dividends? ›
3. What is the current share price of Unjha Formulations Ltd ? ›
4. What is the 52-week high and low of Unjha Formulations Ltd ? ›
Start SIP in Unjha Formulations Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
